TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: (COPD History Assessment In SpaiN): "Estudio Sobre la Evolución Multidimensional de la Enfermedad Pulmonar Obstructiva Crónica (EPOC)".
Brief Summary: The research project CHAIN (COPD Assessment History in Spain): "A Multidimensional Study on the Evolution of Chronic Obstructive Pulmonary Disease (COPD)is a multicentre, observational study conducted in several areas of Spain aimed to better define COPD natural history and its phenotypes


Options:
A: Arm Label: P; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion HCl ER | Intervention Type: DRUG; Name: Bupropion HCl ER; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): P
B: Arm Label: COPD cohort; Type: N/A; Interventions: N/A | Arm Label: Control cohort; Type: N/A; Interventions: N/A
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Arm Label: Standard cognitive-behavioural smoking cessation treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard cognitive-behavioural smoking cessation treatment | Arm Label: Standard smoking cessation treatment and behavioral activation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard cognitive-behavioural smoking cessation treatment and behavioural activation | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Standard cognitive-behavioural smoking cessation treatment; Assigned to Arm(s): Standard cognitive-behavioural smoking cessation treatment | Intervention Type: BEHAVIORAL; Name: Standard cognitive-behavioural smoking cessation treatment and behavioural activation; Assigned to Arm(s): Standard smoking cessation treatment and behavioral activation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dosing Study of Massage for Neck Pain
Brief Summary: This study is designed to determine the most effective dose of massage for persons with chronic neck pain. This information is necessary before more definitive studies can be conducted.


Options:
A: Arm Label: High dose spinal manipulation; Type: EXPERIMENTAL; Interventions: Other: Spinal Manipulation | Arm Label: Moderate dose spinal manipulation; Type: EXPERIMENTAL; Interventions: Other: Spinal Manipulation, Other: Light Massage | Arm Label: Low dose spinal manipulation; Type: EXPERIMENTAL; Interventions: Other: Spinal Manipulation, Other: Light Massage | Arm Label: High dose massage; Type: OTHER; Interventions: Other: Light Massage | Intervention Type: OTHER; Name: Spinal Manipulation; Assigned to Arm(s): High dose spinal manipulation, Low dose spinal manipulation, Moderate dose spinal manipulation | Intervention Type: OTHER; Name: Light Massage; Assigned to Arm(s): High dose massage, Low dose spinal manipulation, Moderate dose spinal manipulation
B: Arm Label: Manual Therapy + Analgesic therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual Therapy, Device: Analgesic therapy | Arm Label: Myofascial Release + Analgesic therapy; Type: EXPERIMENTAL; Interventions: Other: Myofascial Release Therapy, Device: Analgesic therapy | Intervention Type: OTHER; Name: Manual Therapy; Assigned to Arm(s): Manual Therapy + Analgesic therapy | Intervention Type: OTHER; Name: Myofascial Release Therapy; Assigned to Arm(s): Myofascial Release + Analgesic therapy | Intervention Type: DEVICE; Name: Analgesic therapy; Assigned to Arm(s): Manual Therapy + Analgesic therapy, Myofascial Release + Analgesic therapy
C: Arm Label: Exercise and connective tissue massage; Type: EXPERIMENTAL; Interventions: Behavioral: "Exercise" and "connective tissue massage" | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: "Exercise" | Intervention Type: BEHAVIORAL; Name: "Exercise" and "connective tissue massage"; Assigned to Arm(s): Exercise and connective tissue massage | Intervention Type: BEHAVIORAL; Name: "Exercise"; Assigned to Arm(s): Exercise
D: Arm Label: Massage Dose 1; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 2; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 3; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 4; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 5; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 6; Type: EXPERIMENTAL; Interventions: Other: Massage | Intervention Type: OTHER; Name: Massage; Assigned to Arm(s): Massage - Dose 2, Massage - Dose 3, Massage - Dose 4, Massage - Dose 5, Massage - Dose 6, Massage Dose 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Oral vs Intravenous Proton Pump Inhibitor（PPI） in Patients With Peptic Ulcer Bleeding After Successful Endoscopic Therapy- a Prospective Randomized Comparative Trial
Brief Summary: A bleeding peptic ulcer remains a serious medical problem with significant morbidity and mortality. Endoscopic therapy significantly reduces further bleeding, surgery, and mortality in patients with bleeding peptic ulcers and is now recommended as the first hemostatic modality for these patients.

In the past few years, adjuvant use of a high-dose proton pump inhibitor (PPI) after endoscopic therapy has been endorsed in some studies. Laine and Javid et al found that oral PPI and IV PPI had a similar intragastric pH response in the past two years. Therefore, whether oral can replace IV in the management of peptic ulcer bleeding is the objective in this study.

The investigators enrolled 130 patients with active bleeding or nonbleeding visible vessels（NBVV） in this study. They are randomly assigned as oral lansoprazole or IV nexium group. All patients receive successful endoscopic therapy with heater probe or hemoclip placement.

In the lansoprazole group (N=65), 30 mg four times daily is given orally for three days. Thereafter, the patients receive 30 mg lansoprazole orally daily for two months. In the nexium group, 160 mg/day continuous infusion is given for three days. Thereafter, the patients receive 40 mg nexium orally daily for two months.

The primary end point is recurrent bleeding before discharge and within 14 days. At day 14, volume of blood transfused, number of surgeries performed, and the mortality rates of the two groups are compared as well.


Options:
A: Arm Label: lansoprazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: lansoprazole | Arm Label: esomeprazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole | Intervention Type: DRUG; Name: lansoprazole; Assigned to Arm(s): lansoprazole | Intervention Type: DRUG; Name: esomeprazole; Assigned to Arm(s): esomeprazole
B: Intervention Type: DRUG; Name: Omeprazole; Assigned to Arm(s): N/A
C: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Omeprazole | Intervention Type: DRUG; Name: Omeprazole; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: High dose pantoprazole infusion | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard dose pantoprazole infusion | Intervention Type: DRUG; Name: High dose pantoprazole infusion; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Standard dose pantoprazole infusion; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients
Brief Summary: This was a double-blind randomized study with three treatment arms: clozapine, olanzapine and haloperidol. We compared these three medications in the treatment of aggressive behavior over a 12 week period.


Options:
A: Arm Label: clozapine; Type: EXPERIMENTAL; Interventions: Drug: Clozapine | Arm Label: Olanzapine; Type: EXPERIMENTAL; Interventions: Drug: Olanzapine | Arm Label: Haloperidol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Haloperidol | Intervention Type: DRUG; Name: Clozapine; Assigned to Arm(s): clozapine | Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): Olanzapine | Intervention Type: DRUG; Name: Haloperidol; Assigned to Arm(s): Haloperidol
B: Arm Label: Intramuscular ziprasidone; Type: EXPERIMENTAL; Interventions: Drug: Intramuscular ziprasidone mesylate | Arm Label: Intramuscular haloperidol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intramuscular haloperidol | Intervention Type: DRUG; Name: Intramuscular ziprasidone mesylate; Assigned to Arm(s): Intramuscular ziprasidone | Intervention Type: DRUG; Name: Intramuscular haloperidol; Assigned to Arm(s): Intramuscular haloperidol
C: Intervention Type: DRUG; Name: aripiprazole; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Intramuscular Olanzepine 10 mg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Intramuscular Haloperidol 5-10 mg + Promethazine 25-50 mg; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I, Randomized, Single-Blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of the NVGH Glycoconjugate Vaccine Against S. Typhi in Adult Subjects 18 to 40 Years of Age.
Brief Summary: This trial is aimed to evaluate the safety and immunogenicity profiles of a new Vi-CRM197 conjugate vaccine against S. Typhi in healthy human adults in comparison with the currently licensed Vi polysaccharide vaccine.


Options:
A: Arm Label: NVGH Vi-CRM197 conjugate vaccine; Type: EXPERIMENTAL; Interventions: Biological: NVGH Vi-CRM197 | Arm Label: Vi-polysaccharide vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: Typherix | Intervention Type: BIOLOGICAL; Name: Typherix; Assigned to Arm(s): Vi-polysaccharide vaccine | Intervention Type: BIOLOGICAL; Name: NVGH Vi-CRM197; Assigned to Arm(s): NVGH Vi-CRM197 conjugate vaccine
B: Arm Label: M01ZH09 vaccine; Type: EXPERIMENTAL; Interventions: Biological: M10ZH09 vaccine | Arm Label: Vaccine placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Vaccine placebo (excipients only) | Arm Label: Ty21a vaccine; Type: OTHER; Interventions: Biological: Ty21a | Intervention Type: BIOLOGICAL; Name: Vaccine placebo (excipients only); Assigned to Arm(s): Vaccine placebo | Intervention Type: BIOLOGICAL; Name: Ty21a; Assigned to Arm(s): Ty21a vaccine | Intervention Type: BIOLOGICAL; Name: M10ZH09 vaccine; Assigned to Arm(s): M01ZH09 vaccine
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Typhoid Vi vaccine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: Hepatitis A vaccine | Intervention Type: BIOLOGICAL; Name: Typhoid Vi vaccine; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Hepatitis A vaccine; Assigned to Arm(s): 2
D: Arm Label: NVGH Vi-CRM197 conjugate vaccine 12.5 mcg; Type: EXPERIMENTAL; Interventions: Biological: NVGH Vi-CRM197 12.5 mcg | Arm Label: NVGH Vi-CRM197 conjugate vaccine 5 mcg; Type: EXPERIMENTAL; Interventions: Biological: NVGH Vi-CRM197 5.0 mcg | Arm Label: NVGH Vi-CRM197 conjugate vaccine 1.25 mcg; Type: EXPERIMENTAL; Interventions: Biological: NVGH Vi-CRM197 1.25 mcg | Arm Label: Typherix; Type: ACTIVE_COMPARATOR; Interventions: Biological: Vi-polysaccharide vaccine | Intervention Type: BIOLOGICAL; Name: NVGH Vi-CRM197 12.5 mcg; Assigned to Arm(s): NVGH Vi-CRM197 conjugate vaccine 12.5 mcg | Intervention Type: BIOLOGICAL; Name: NVGH Vi-CRM197 5.0 mcg; Assigned to Arm(s): NVGH Vi-CRM197 conjugate vaccine 5 mcg | Intervention Type: BIOLOGICAL; Name: NVGH Vi-CRM197 1.25 mcg; Assigned to Arm(s): NVGH Vi-CRM197 conjugate vaccine 1.25 mcg | Intervention Type: BIOLOGICAL; Name: Vi-polysaccharide vaccine; Assigned to Arm(s): Typherix

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improved Effectiveness of Smoking Cessation Programs for Minnesota Priority Populations
Brief Summary: This study uses a proactive outreach strategy, coupled with free nicotine replacement therapy (NRT) to increase the population impact of tobacco cessation treatment for diverse, low income smokers. Population impact is the product of treatment utilization (i.e., reach or exposure) and treatment efficacy (i.e., smoking abstinence rates among those who utilize treatment).


Options:
A: Arm Label: PRO+NRT+TC; Type: EXPERIMENTAL; Interventions: Other: proactive outreach (PRO), Other: telephone counseling (TC), Other: Nicotine replacement therapy (NRT) | Arm Label: Usual Care (UC); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care (UC) | Intervention Type: OTHER; Name: proactive outreach (PRO); Assigned to Arm(s): PRO+NRT+TC | Intervention Type: OTHER; Name: telephone counseling (TC); Assigned to Arm(s): PRO+NRT+TC | Intervention Type: OTHER; Name: Nicotine replacement therapy (NRT); Assigned to Arm(s): PRO+NRT+TC | Intervention Type: OTHER; Name: Usual care (UC); Assigned to Arm(s): Usual Care (UC)
B: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement
C: Arm Label: Integrated Cessation Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Treatment | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tobacco Treatment | Intervention Type: BEHAVIORAL; Name: Tobacco Treatment; Assigned to Arm(s): Integrated Cessation Counseling, Usual Care
D: Arm Label: High intensity disease management; Type: EXPERIMENTAL; Interventions: Behavioral: High intensity disease management, Drug: Bupropion | Arm Label: Low intensity disease management; Type: EXPERIMENTAL; Interventions: Behavioral: Low intensity disease management, Drug: Bupropion | Arm Label: Comparison group; Type: OTHER; Interventions: Behavioral: Comparison group, Drug: Bupropion | Intervention Type: BEHAVIORAL; Name: High intensity disease management; Assigned to Arm(s): High intensity disease management | Intervention Type: BEHAVIORAL; Name: Low intensity disease management; Assigned to Arm(s): Low intensity disease management | Intervention Type: BEHAVIORAL; Name: Comparison group; Assigned to Arm(s): Comparison group | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Comparison group, High intensity disease management, Low intensity disease management

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tobacco Tactics Website for Operating Engineers
Brief Summary: This is a clustered randomized control trial to test the Tobacco Tactics intervention among Operating Engineers (heavy equipment workers). The intervention group will be directed to the Tobacco Tactics website, and the control group will be directed to the state supported 1-800 quit-now telephone hotline during routine annual safety training that all Operating Engineers are required to attend. The web-based quitting intervention includes provision of over-the-counter nicotine replacement therapy and will be followed by nurse email and/or telephone counseling. It is expected that Operating Engineers who are randomized to the Tobacco Tactics website intervention will have at least equal or greater decreases in smoking at 30-day and 6-month follow-up compared to those randomized to the 1-800-QUIT-NOW quit line. In addition, the investigators expect to find that Operating Engineers randomized to the Tobacco Tactics website intervention will: a) be able to accomplish tasks; b) be able to accomplish goals with skill and speed; c) be able to operate the system; d) be satisfied with the website; e) access the site repeatedly; and f) spend time on the site during the intervention period.


Options:
A: Arm Label: Novel workplace - first half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Novel workplace - second half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Workplace consisting of two height-adjustable desks; Assigned to Arm(s): Novel workplace - first half, Novel workplace - second half
B: Arm Label: 1-800-QUIT-NOW Telephone Hotline; Type: OTHER; Interventions: Other: 1-800-QUIT-NOW Telephone Hotline | Arm Label: Tobacco Tactics Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Tactics Web-Based Intervention | Intervention Type: BEHAVIORAL; Name: Tobacco Tactics Web-Based Intervention; Assigned to Arm(s): Tobacco Tactics Intervention | Intervention Type: OTHER; Name: 1-800-QUIT-NOW Telephone Hotline; Assigned to Arm(s): 1-800-QUIT-NOW Telephone Hotline
C: Arm Label: Stair walking; Type: EXPERIMENTAL; Interventions: Behavioral: Stair walking | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stair walking | Intervention Type: BEHAVIORAL; Name: Stair walking; Assigned to Arm(s): Control, Stair walking
D: Arm Label: Worksite Environmental Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: weight gain prevention | Arm Label: No-contact control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: weight gain prevention; Assigned to Arm(s): Worksite Environmental Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lumbar Segmental Stabilization, Strengthening and Stretching in Chronic Low Back Pain: a Comparative Study
Brief Summary: The purpose of this study was to compare the efficacy of three exercise programs in patients with chronic low back pain: Segmental stabilization, superficial strengthening and stretching. Groups were contrasted regarding pain, functional disability and TrA muscle activation capacity. The three groups of exercise improved pain and functional disabilities, and the Segmental stabilization group was better in the ability to recruit TrA muscle.


Options:
A: Arm Label: Education and Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and standard care | Arm Label: Internet Mediated Enhanced Pedometer; Type: EXPERIMENTAL; Interventions: Other: Education and standard care, Behavioral: Internet mediated enhanced pedometer intervention | Intervention Type: OTHER; Name: Education and standard care; Assigned to Arm(s): Education and Standard Care, Internet Mediated Enhanced Pedometer | Intervention Type: BEHAVIORAL; Name: Internet mediated enhanced pedometer intervention; Assigned to Arm(s): Internet Mediated Enhanced Pedometer
B: Arm Label: Stabilization group; Type: EXPERIMENTAL; Interventions: Other: Stabilization , strengthening and stretching | Arm Label: Strengthening group; Type: EXPERIMENTAL; Interventions: Other: Stabilization , strengthening and stretching | Arm Label: Stretching group; Type: EXPERIMENTAL; Interventions: Other: Stabilization , strengthening and stretching | Intervention Type: OTHER; Name: Stabilization , strengthening and stretching; Assigned to Arm(s): Stabilization group, Strengthening group, Stretching group
C: Arm Label: Lumbar stabilization exercises; Type: EXPERIMENTAL; Interventions: Other: Lumbar stabilization exercises | Arm Label: TENS group; Type: EXPERIMENTAL; Interventions: Other: Lumbar stabilization exercises | Intervention Type: OTHER; Name: Lumbar stabilization exercises; Assigned to Arm(s): Lumbar stabilization exercises, TENS group
D: Arm Label: Motor Control Exercise Plus Patient Education; Type: EXPERIMENTAL; Interventions: Behavioral: Motor Control Exercise, Behavioral: Patient Education | Arm Label: Motor Control Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Motor Control Exercise | Arm Label: Patient Education; Type: EXPERIMENTAL; Interventions: Behavioral: Patient Education | Intervention Type: BEHAVIORAL; Name: Motor Control Exercise; Assigned to Arm(s): Motor Control Exercise, Motor Control Exercise Plus Patient Education | Intervention Type: BEHAVIORAL; Name: Patient Education; Assigned to Arm(s): Motor Control Exercise Plus Patient Education, Patient Education

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lumbar Segmental Stabilization, Strengthening and Stretching in Chronic Low Back Pain: a Comparative Study
Brief Summary: The purpose of this study was to compare the efficacy of three exercise programs in patients with chronic low back pain: Segmental stabilization, superficial strengthening and stretching. Groups were contrasted regarding pain, functional disability and TrA muscle activation capacity. The three groups of exercise improved pain and functional disabilities, and the Segmental stabilization group was better in the ability to recruit TrA muscle.


Options:
A: Arm Label: Stabilization group; Type: EXPERIMENTAL; Interventions: Other: Stabilization , strengthening and stretching | Arm Label: Strengthening group; Type: EXPERIMENTAL; Interventions: Other: Stabilization , strengthening and stretching | Arm Label: Stretching group; Type: EXPERIMENTAL; Interventions: Other: Stabilization , strengthening and stretching | Intervention Type: OTHER; Name: Stabilization , strengthening and stretching; Assigned to Arm(s): Stabilization group, Strengthening group, Stretching group
B: Arm Label: Core stabilization and psychosocial education; Type: EXPERIMENTAL; Interventions: Behavioral: Core stabilization and psychosocial education | Arm Label: Core stabilization exercise only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Core stabilization exercise only | Arm Label: Psychosocial education class only.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychosocial education class only | Arm Label: Traditional Army training; Type: OTHER; Interventions: Behavioral: Traditional Army training | Intervention Type: BEHAVIORAL; Name: Traditional Army training; Assigned to Arm(s): Traditional Army training | Intervention Type: BEHAVIORAL; Name: Core stabilization exercise only; Assigned to Arm(s): Core stabilization exercise only | Intervention Type: BEHAVIORAL; Name: Psychosocial education class only; Assigned to Arm(s): Psychosocial education class only. | Intervention Type: BEHAVIORAL; Name: Core stabilization and psychosocial education; Assigned to Arm(s): Core stabilization and psychosocial education
C: Intervention Type: PROCEDURE; Name: Mod. functional restoration-Individ. dynamic back-muscle; Assigned to Arm(s): N/A
D: Arm Label: Treatment based on Movement System Impairment based model; Type: EXPERIMENTAL; Interventions: Other: Treatment based on Movement System Impairment model | Arm Label: General exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: General exercise | Intervention Type: OTHER; Name: Treatment based on Movement System Impairment model; Assigned to Arm(s): Treatment based on Movement System Impairment based model | Intervention Type: OTHER; Name: General exercise; Assigned to Arm(s): General exercise

Answer: A